497 related articles for article (PubMed ID: 11809792)
1. Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6.
Mizukami J; Takaesu G; Akatsuka H; Sakurai H; Ninomiya-Tsuji J; Matsumoto K; Sakurai N
Mol Cell Biol; 2002 Feb; 22(4):992-1000. PubMed ID: 11809792
[TBL] [Abstract][Full Text] [Related]
2. TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB.
Lee SW; Han SI; Kim HH; Lee ZH
J Biochem Mol Biol; 2002 Jul; 35(4):371-6. PubMed ID: 12296995
[TBL] [Abstract][Full Text] [Related]
3. Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis.
Zhang Z; Jimi E; Bothwell AL
J Immunol; 2003 Oct; 171(7):3620-6. PubMed ID: 14500659
[TBL] [Abstract][Full Text] [Related]
4. TAB2, TRAF6 and TAK1 are involved in NF-kappaB activation induced by the TNF-receptor, Edar and its adaptator Edaradd.
Morlon A; Munnich A; Smahi A
Hum Mol Genet; 2005 Dec; 14(23):3751-7. PubMed ID: 16251197
[TBL] [Abstract][Full Text] [Related]
5. TAB2, a novel adaptor protein, mediates activation of TAK1 MAPKKK by linking TAK1 to TRAF6 in the IL-1 signal transduction pathway.
Takaesu G; Kishida S; Hiyama A; Yamaguchi K; Shibuya H; Irie K; Ninomiya-Tsuji J; Matsumoto K
Mol Cell; 2000 Apr; 5(4):649-58. PubMed ID: 10882101
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways.
Zhang YH; Heulsmann A; Tondravi MM; Mukherjee A; Abu-Amer Y
J Biol Chem; 2001 Jan; 276(1):563-8. PubMed ID: 11032840
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta.
Jiang Z; Mak TW; Sen G; Li X
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3533-8. PubMed ID: 14982987
[TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.
Moon G; Kim J; Min Y; Wi SM; Shim JH; Chun E; Lee KY
Cell Signal; 2015 Dec; 27(12):2524-33. PubMed ID: 26432169
[TBL] [Abstract][Full Text] [Related]
9. TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo.
Shim JH; Xiao C; Paschal AE; Bailey ST; Rao P; Hayden MS; Lee KY; Bussey C; Steckel M; Tanaka N; Yamada G; Akira S; Matsumoto K; Ghosh S
Genes Dev; 2005 Nov; 19(22):2668-81. PubMed ID: 16260493
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal inhibition between the transforming growth factor-β-activated kinase 1 (TAK1) and apoptosis signal-regulating kinase 1 (ASK1) mitogen-activated protein kinase kinase kinases and its suppression by TAK1-binding protein 2 (TAB2), an adapter protein for TAK1.
Kim SY; Shim JH; Chun E; Lee KY
J Biol Chem; 2012 Jan; 287(5):3381-91. PubMed ID: 22167179
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 (IL-1) receptor-associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol.
Jiang Z; Ninomiya-Tsuji J; Qian Y; Matsumoto K; Li X
Mol Cell Biol; 2002 Oct; 22(20):7158-67. PubMed ID: 12242293
[TBL] [Abstract][Full Text] [Related]
12. TAK1-dependent signaling requires functional interaction with TAB2/TAB3.
Besse A; Lamothe B; Campos AD; Webster WK; Maddineni U; Lin SC; Wu H; Darnay BG
J Biol Chem; 2007 Feb; 282(6):3918-28. PubMed ID: 17158449
[TBL] [Abstract][Full Text] [Related]
13. Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors.
Sugatani T; Alvarez UM; Hruska KA
J Cell Biochem; 2003 Sep; 90(1):59-67. PubMed ID: 12938156
[TBL] [Abstract][Full Text] [Related]
14. Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR .
Jiang Z; Zamanian-Daryoush M; Nie H; Silva AM; Williams BR; Li X
J Biol Chem; 2003 May; 278(19):16713-9. PubMed ID: 12609980
[TBL] [Abstract][Full Text] [Related]
15. The scaffold protein RACK1 mediates the RANKL-dependent activation of p38 MAPK in osteoclast precursors.
Lin J; Lee D; Choi Y; Lee SY
Sci Signal; 2015 Jun; 8(379):ra54. PubMed ID: 26038599
[TBL] [Abstract][Full Text] [Related]
16. Evidence that receptor activator of nuclear factor (NF)-kappaB ligand can suppress cell proliferation and induce apoptosis through activation of a NF-kappaB-independent and TRAF6-dependent mechanism.
Bharti AC; Takada Y; Shishodia S; Aggarwal BB
J Biol Chem; 2004 Feb; 279(7):6065-76. PubMed ID: 14645259
[TBL] [Abstract][Full Text] [Related]
17. TAK1 is a component of the Epstein-Barr virus LMP1 complex and is essential for activation of JNK but not of NF-kappaB.
Uemura N; Kajino T; Sanjo H; Sato S; Akira S; Matsumoto K; Ninomiya-Tsuji J
J Biol Chem; 2006 Mar; 281(12):7863-72. PubMed ID: 16446357
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1 (IL-1) receptor-associated kinase leads to activation of TAK1 by inducing TAB2 translocation in the IL-1 signaling pathway.
Takaesu G; Ninomiya-Tsuji J; Kishida S; Li X; Stark GR; Matsumoto K
Mol Cell Biol; 2001 Apr; 21(7):2475-84. PubMed ID: 11259596
[TBL] [Abstract][Full Text] [Related]
19. Activation of NF-kappaB by RANK requires tumor necrosis factor receptor-associated factor (TRAF) 6 and NF-kappaB-inducing kinase. Identification of a novel TRAF6 interaction motif.
Darnay BG; Ni J; Moore PA; Aggarwal BB
J Biol Chem; 1999 Mar; 274(12):7724-31. PubMed ID: 10075662
[TBL] [Abstract][Full Text] [Related]
20. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.
Takayanagi H; Ogasawara K; Hida S; Chiba T; Murata S; Sato K; Takaoka A; Yokochi T; Oda H; Tanaka K; Nakamura K; Taniguchi T
Nature; 2000 Nov; 408(6812):600-5. PubMed ID: 11117749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
